Resources
96 Results (showing 41 - 50)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 7/6/2020 (updated 3/28/2024)
This toolkit was produced by the University of Minnesota Rural Health Research Center, in partnership with the NORC Walsh Center for Rural Health Analysis, and in collaboration with the Rural Health Information Hub (RHIhub).
Posted 6/16/2020 (updated 3/28/2024)
This cross-sectional study included all counties and county-equivalent divisions in the US in 2016. Data on racial/ethnic population distribution were derived from the American Community Survey, and data on locations of facilities providing methadone and buprenorphine were obtained from Substance Abuse and Mental Health Services Administration databases.
Posted 6/12/2020 (updated 3/28/2024)
Mother & Baby Substance Exposure Toolkit Best Practices All Best Practices came as a part of the California Medication Assisted Treatment Expansion Project
Posted 5/22/2020 (updated 3/28/2024)
To identify Finnegan Neonatal Abstinence Scoring Tool tems independently associated with the decision to use pharmacologic therapy and to simplify the FNAST while minimizing loss of information for the treatment decision.
Posted 5/22/2020 (updated 3/28/2024)
As a response to the ongoing opioid crisis, every US state has increased access to naloxone through a variety of expanded prescribing methods, such as standing orders or protocols. This reports examines the impact of a standing order for rural Georgia pharmacies.
Posted 5/18/2020 (updated 3/28/2024)
Overreliance on opioid medications is emblematic of a health care system that incentivizes quick, simplistic answers to complex physical and mental health needs.
Posted 11/21/2019 (updated 3/28/2024)
Opioid overdose is reversible through the timely administration of naloxone, which has been used by emergency medical services for decades.
Posted 11/19/2019 (updated 3/28/2024)
Posted 4/27/2020 (updated 3/28/2024)
To mitigate the opioid overdose crisis, states have implemented a variety of legal interventions aimed at increasing access to the opioid antagonist naloxone. Recently, Virginia and Vermont mandated the coprescription of naloxone for potentially at-risk patients.
Posted 4/24/2020 (updated 3/28/2024)
This webinar was hosted by the SAMHSA GAINS Center on January 14, 2020. The webinar slides and supplemental resources are now available.